{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:22:29Z","timestamp":1792786949395,"version":"4.5.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2159,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2017,2,12]],"date-time":"2017-02-12T00:00:00Z","timestamp":1486857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T00:00:00Z","timestamp":1484870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"TherapeuticsMD","id":[{"id":"https:\/\/ror.org\/03993n266","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Postmenopausal women's knowledge about vulvar and vaginal atrophy (VVA) and available treatment options has historically been inadequate. Recent direct-to-consumer marketing and educational efforts would have been expected to increase awareness and treatment options.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To compare results of the Women's EMPOWER survey with other available VVA surveys to assess progress in women's understanding and approaches to treatment of VVA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Women's EMPOWER survey, an internet-based survey of US women with VVA symptoms, assessed women's awareness of VVA and their behaviors and attitudes associated with symptom treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>These survey results were compared with previously published results of the Revealing Vaginal Effects at Mid-Life (REVEAL), Women's Voices in Menopause (WVM), Vaginal Health: Insight, Views, &amp; Attitudes (VIVA), Clarifying Vaginal Atrophy's Impact on Sex and Relationship (CLOSER), and Real Women's Views of Treatment Options for Menopausal Vaginal Changes (REVIVE) surveys.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Results of the Women's EMPOWER survey were consistent with those of past VVA surveys and showed that postmenopausal women generally failed to recognize VVA and its chronic, progressive process and that they were reluctant to discuss vaginal or sexual symptoms with their health care professionals (HCPs). However, women indicated a strong desire for accurate medical information about VVA from their health care professionals and a willingness to learn if HCPs would initiate the conversation. Most women believed that vaginal symptoms are a normal part of aging and they just need to cope with the symptoms. In the United States, women were most concerned with safety-related issues, including increased risk of breast cancer, side effects, and systemic absorption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The Women's EMPOWER survey demonstrates and reinforces that even with multimedia marketing and educational strategies in the years after other major VVA surveys, minimal progress has been made toward increasing women's awareness of, knowledge about, or understanding of VVA. Based on these data, a focus on initiating discussions and education with postmenopausal women so that they better comprehend VVA as a chronic progressive medical condition (not just aging), the symptoms associated with VVA, and the benefit-risk profile regarding treatment options is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.jsxm.2017.01.011","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T10:08:16Z","timestamp":1486980496000},"page":"425-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"title":["The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate"],"prefix":"10.1093","volume":"14","author":[{"given":"Michael","family":"Krychman","sequence":"first","affiliation":[{"name":"Southern California Center for Sexual Health and Survivorship Medicine Inc , Newport Beach, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelli","family":"Graham","sequence":"additional","affiliation":[{"name":"TherapeuticsMD , Boca Raton, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Bernick","sequence":"additional","affiliation":[{"name":"TherapeuticsMD , Boca Raton, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Mirkin","sequence":"additional","affiliation":[{"name":"TherapeuticsMD , Boca Raton, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl A.","family":"Kingsberg","sequence":"additional","affiliation":[{"name":"University Hospitals Cleveland Medical Center \u00a0 , Cleveland, OH , USA"},{"name":"MacDonald Women's Hospital \u00a0 , Cleveland, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,2,12]]},"reference":[{"key":"2023011111045909600_bib1","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society","volume":"21","author":"Portman","year":"2014","journal-title":"Menopause"},{"key":"2023011111045909600_bib2","first-page":"2133","article-title":"Prevalence and impact of vaginal symptoms among postmenopausal women","volume":"6","author":"Santoro","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"2023011111045909600_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.maturitas.2010.08.001","article-title":"Women's voices in the menopause: results from an international survey on vaginal atrophy","volume":"67","author":"Nappi","year":"2010","journal-title":"Maturitas"},{"key":"2023011111045909600_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/13697137.2011.647840","article-title":"Vaginal Health: Insights, Views & Attitudes (VIVA)\u2014results from an international survey","volume":"15","author":"Nappi","year":"2012","journal-title":"Climacteric"},{"key":"2023011111045909600_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4065\/mcp.2009.0413","article-title":"Vulvovaginal atrophy","volume":"85","author":"Mac Bride","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"2023011111045909600_bib6","article-title":"Annual estimates of the resident population for selected age groups by sex: April 1, 2010 to July 1, 2015","author":"US Census Bureau"},{"key":"2023011111045909600_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1258\/175404507780796424","article-title":"Women's attitudes to hormone replacement therapy, alternative therapy and sexual health: a web-based survey","volume":"13","author":"Cumming","year":"2007","journal-title":"Menopause Int"},{"key":"2023011111045909600_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2147\/IJWH.S44579","article-title":"Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy","volume":"5","author":"Parish","year":"2013","journal-title":"Int J Womens Health"},{"key":"2023011111045909600_bib9","volume-title":"REVEAL: Revealing Vaginal Effects at Mid-Life: surveys of postmenopausal women and health care professionals who treat postmenopausal women","author":"Krychman","year":"2009"},{"key":"2023011111045909600_bib10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/GME.0b013e318287342d","article-title":"Vaginal health in the United States: results from the Vaginal Health: Insights, Views & Attitudes survey","volume":"20","author":"Simon","year":"2013","journal-title":"Menopause"},{"key":"2023011111045909600_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.maturitas.2013.05.003","article-title":"The CLOSER survey: impact of postmenopausal vaginal discomfort on relationships between women and their partners in Northern and Southern Europe","volume":"75","author":"Nappi","year":"2013","journal-title":"Maturitas"},{"key":"2023011111045909600_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/GME.0b013e318295236f","article-title":"Clarifying Vaginal Atrophy's Impact on Sex and Relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners","volume":"21","author":"Simon","year":"2014","journal-title":"Menopause"},{"key":"2023011111045909600_bib13","first-page":"1790","article-title":"Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey","volume":"10","author":"Kingsberg","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"2023011111045909600_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/13697137.2015.1107039","article-title":"Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey","volume":"19","author":"Nappi","year":"2016","journal-title":"Climacteric"},{"key":"2023011111045909600_bib15","article-title":"Pfizer brings humor to menopause marketing","author":"Pfizer Inc"},{"key":"2023011111045909600_bib16","article-title":"Marketing menopause: the definition of a tough sell","author":"Vancouver Sun"},{"key":"2023011111045909600_bib17","article-title":"New Shionogi Inc advertising campaign features a personal story about painful sex after menopause","author":"Shionogi Inc"},{"key":"2023011111045909600_bib18","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/GME.0000000000000783","article-title":"The Women's EMPOWER survey: identifying women's perceptions on vulvar and vaginal atrophy (VVA) and treatment. Presented at the 27th Annual Meeting of The North American Menopause Society October 5\u20138, 2016, Orlando, FL (S-10)","volume":"23","author":"Kingsberg","year":"2016","journal-title":"Menopause"},{"key":"2023011111045909600_bib19","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/GME.0b013e3182a122c2","article-title":"Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society","volume":"20","year":"2013","journal-title":"Menopause"},{"key":"2023011111045909600_bib20","article-title":"New survey reports some postmenopausal women endure vaginal and sexual symptoms of menopause for more than two years before discussing with health care\u00a0professional","author":"HealthyWomen"},{"key":"2023011111045909600_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/AOG.0b013e318265df42","article-title":"A\u00a0sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999\u20132010","volume":"120","author":"Sprague","year":"2012","journal-title":"Obstet Gynecol"},{"key":"2023011111045909600_bib22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/AOG.0000000000000469","article-title":"Trends of postmenopausal estrogen plus progestin prevalence in the United States between 1970 and 2010","volume":"124","author":"Jewett","year":"2014","journal-title":"Obstet Gynecol"},{"key":"2023011111045909600_bib23","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative randomized controlled trial","volume":"291","author":"WHI Steering Committee","year":"2004","journal-title":"JAMA"},{"key":"2023011111045909600_bib24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/01.AOG.0000441353.20693.78","article-title":"Management of menopausal symptoms. Practice bulletin no. 141. American College of Obstetricians and Gynecologists","volume":"123","year":"2014","journal-title":"Obstet Gynecol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609517300590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609517300590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/14\/3\/425\/48525222\/jsm_14_3_425.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/14\/3\/425\/48525222\/jsm_14_3_425.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T09:43:25Z","timestamp":1673430205000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/14\/3\/425\/6973344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,12]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,2,12]]},"published-print":{"date-parts":[[2017,3,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2017.01.011","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2017,3]]},"published":{"date-parts":[[2017,2,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2017.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017, The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine.","name":"copyright","label":"Copyright"}]}}